Maternal care for other isoimmunization - what does this mean
Maternal isoimmunization occurs when a pregnant woman's immune system produces antibodies that attack her fetus's red blood cells, causing anemia and other serious complications. this is usually caused by a mismatch between the mother and fetus's blood types, and can be prevented by avoiding rh-incompatible pregnancies and by administering rh immune globulin during pregnancy.
What happens during the disease - maternal care for other isoimmunization
Maternal isoimmunization occurs when a pregnant woman develops antibodies to fetal red blood cells due to the presence of a different blood type between the mother and fetus. this can lead to destruction of the fetal red blood cells (hemolysis) and cause anemia in the fetus, which can lead to serious complications such as fetal growth restriction, preterm labor, and even death. maternal care for this condition includes monitoring for signs of anemia in the fetus, and if necessary, administering rh immunoglobulin to the mother to reduce the risk of further fetal red blood cell destruction.
Treatment and Medical Assistance
Main Goal: To reduce the risk of complications due to isoimmunization
- Identify and monitor maternal and fetal blood type
- Provide appropriate antenatal care to monitor maternal and fetal health
- Administer Rh immunoglobulin to the mother at 28 weeks of gestation
- Perform regular ultrasounds to monitor fetal growth
- Administer appropriate antibiotics to the mother to prevent infection
- Perform cord blood sampling to monitor fetal anemia
- Administer intrauterine transfusions as needed
- Perform regular fetal monitoring
- Deliver the baby by cesarean section if necessary
6 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Maternal care for other isoimmunization - Prevention
Maternal care for other isoimmunization can be prevented by ensuring that pregnant women receive prenatal care, including rh typing and antibody screening during the first trimester. additionally, rh immunoglobulin should be administered to rh-negative women at 28 weeks of gestation and again within 72 hours of delivery of an rh-positive baby.